Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of paricalcitol on inflammation, oxidative stress, nutrition, and anemia in chronic kidney disease
2011-000249-18Phase 3Completed
- Sponsor
- RICARDO MOUZO MIRCO
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of paricalcitol in chronic kidney disease (CKD) (3 arms), sponsored by RICARDO MOUZO MIRCO. Started Sep 2011; status: completed.
02
Drugs
paricalcitol
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2011-000249-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000249-18.